SX
SXTEY
Shenzhen Xunce Technology Co., Ltd.—
Price
Daily candles with volume.
No data for this timeframe.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 8, 2026 Clinical trial readout
Results Pending: SAL0120 (Phase 3) — Completed 68d ago
Trial: A Study to Evaluate the Efficacy and Safety in Participants With Uncontrolled Hypertension on
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 8, 2026
Trial readout
Results Pending: SAL0120 (Phase 3) — Completed 68d ago
Trial: A Study to Evaluate the Efficacy and Safety in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants…
Sep 8, 2026
Trial readout
Results Pending: SAL0120 (Phase 3) — Completed 68d ago
Trial: A Study to Evaluate the Efficacy and Safety in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants…
Aug 27, 2026
Trial readout
Results Pending: SAL0120 (Phase 3) — Completed 56d ago
Trial: A Study to Evaluate the Efficacy and Safety in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants…
Aug 11, 2026
Clinical Trial
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
Phase 3 · COMPLETED
Aug 3, 2026
Clinical Trial
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes
Phase 3 · COMPLETED